Posted on 01/17/2025 12:05:13 PM PST by CondoleezzaProtege
National personal injury law firm Pritzker Hageman has assembled an all-female legal team to pursue litigation on behalf of women who developed meningioma tumors after using Depo-Provera birth control injections.
Compelling scientific research shows that the extremely high doses of the synthetic progestin hormone in Depo-Provera can stimulate the growth of meningiomas.
Depo-Provera was approved for contraceptive use in the United States in 1992, but studies going back to 1983 suggested that levels of synthetic progestin hormones found in Depo-Provera can bind to receptors on meningiomas, accelerating their growth. While these tumors are often called "benign," their location means they can compress the brain and spinal cord and lead to severe complications.
Pritzker Hageman's Depo-Provera litigation aims to expose the fact that Pfizer and other companies failed to adequately warn women of the meningioma risk.
"We want women to have awareness that users of Depo-Provera are at risk," Vanden Heuvel stated.
"The longer you take it, the more likely it is that you would develop a brain tumor," Penner added.
The potential number of women affected is substantial. In 2020, over 2 million prescriptions for Depo-Provera were written in the U.S.
(Excerpt) Read more at kxan.com ...
Strange. Not seeing a definition of women in the article.
I guess they’re ok with a meningioma as long as they’re not burdened by children. So WHO CARES?
That they needed to point out it was an all female team pretty much means it is doomed to fail as the sex of the team is obviously more important than actual legal competence.
Don’t get your hopes up about RFK:
https://nypost.com/2025/01/17/us-news/bill-gates-frankly-impressed-after-3-hour-dinner-with-trump/
📌
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.